公司概覽
業務類別 Medical Devices
業務概覽 Enovis Corp is a medical technology manufacturer and distributor of medical devices used in reconstructive surgery, rehabilitation, pain management, and physical therapy. Its products support patient care from injury prevention through post-surgical or post-injury rehabilitation and treatment of degenerative conditions. The company's reportable segments include Prevention & Recovery and Reconstructive segments. The majority of revenueis derived from the Prevention & Recoverysegment, which includes products that are used by orthopedic specialists, primary care physicians, physical therapists, chiropractors, athletic trainers and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformitiesand sports-related injuries.
公司地址 2711 Centerville Road, Suite 400, Wilmington, DE, USA, 19808
電話號碼 +1 302 252-9160
傳真號碼 +1 800 936-6569
公司網頁 https://www.enovis.com
員工數量 7802
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Phillip Benjamin Berry Senior Vice President and Chief Financial Officer 美元 604.92K 26/02/2026
Mr. Terry D. Ross Group President, Prevention and Recovery 美元 514.92K 26/02/2026
Mr. Damien McDonald Chief Executive Officer and Director 美元 634.62K 06/04/2026
Mr. John Kleckner Vice President, Controller and Chief Accounting Officer -- 26/02/2026
Mr. Bradley J. Tandy Senior Vice President and Chief Legal Officer -- 26/02/2026
Ms. Laura Singleton Senior Vice President and Chief Human Resources Officer -- 15/12/2025
Mr. Louie Vogt Group President, Reconstructive 美元 500.00K 26/02/2026
Mr. Oliver Engert Chief Administrative Officer -- 26/02/2026
 
董事會成員
董事會 職務 更新日期
Ms. Angela S. Lalor Independent Director 06/04/2026
Ms. Sharon L. Wienbar Chairman of the Board 06/04/2026
Mr. Damien McDonald Chief Executive Officer and Director 06/04/2026
Mr. Philip A. Okala Independent Director 06/04/2026
Mr. Brady R. Shirley Director 06/04/2026
Ms. Barbara W. Bodem Independent Director 06/04/2026
Mr. Liam J. Kelly Independent Director 06/04/2026
Mr. Rajiv Vinnakota Independent Director 06/04/2026
Mr. A. Clayton Perfall Independent Director 06/04/2026
Dr. Christine Ortiz, B.S.,M.S.,PhD Independent Director 06/04/2026
 
所屬ETF (更新日期: 02/05/2026 03:57)
代號 名稱 佔比% 持有日期
XHEStt Strt® SPDR® S&P®HlthCrEqpmntETF0.16%29/04/2026
AVSCAvantis US Small Cap Equity ETF0.14%29/04/2026
ITOTiShares Core S&P Total US Stock Mkt ETF0.14%28/04/2026
SMLFiShares U.S. Small-Cap Eq Fac ETF0.13%29/04/2026
TSCVThrivent Small Cap Value ETF0.10%31/12/2025
VFVAVanguard US Value Factor ETF0.10%31/03/2026
ESMLiShares ESG Aware MSCI USA Small-Cap ETF0.09%29/04/2026
FYCFirst Trust Small Cap Gr AlphaDEX® ETF0.09%29/04/2026
VTWVVanguard Russell 2000 Value ETF0.08%31/03/2026
PSCHInvesco S&P SmallCap Health Care ETF0.07%29/04/2026
VTVanguard Total World Stock ETF0.07%31/03/2026
PRFInvesco RAFI US 1000 ETF0.06%29/04/2026
GSSCGoldman Sachs ActiveBeta® US SmCp Eq ETF0.06%29/04/2026
SCHBSchwab US Broad Market ETF™0.05%29/04/2026
FHLCFidelity MSCI Health Care ETF0.05%29/04/2026
ISMDInspire Small/Mid Cap ETF0.04%29/04/2026
BBSCJPMorgan BetaBuilders US Sml Cp Eq ETF0.04%29/04/2026
VFMFVanguard US Multifactor ETF0.03%31/03/2026
SMLVState Street® SPDR® USSmCapLowVolIndETF0.03%29/04/2026
IWViShares Russell 3000 ETF0.02%29/04/2026
  1   2    3    4    5    6  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.